Dr. Xu is an investigator for Cardiovascular clinical trials through the Sutter Heart
& Vascular Institute at Sutter Medical Center Sacramento.
Sutter Institute for Medical Research
2800 L Street, 6th Floor
Sacramento, CA, 95816
(916) 887-4040
SHVICR@sutterhealth.org
Primary Research Interests
Related Clinical Trials
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF)
Randomized, placebo-controlled, parallel-group, multi-center, double-blind, event
driven study of vericiguat in participants with HFrEF.
Investigator: Zijian Xu M.D., Ph.D., FACC
Status: Active, Recruiting
Actelion (Soprano)
Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary
Hypertension After Left Ventricular Assist Device Implantation (SOPRAN
Investigators: John Chin M.D., Zijian Xu M.D., Ph.D., FACC
Status: Active, Recruiting
CardoMEMS (SIMR)
CardioMEMS HF System Post Approval Study
Investigators: Pei-Hsiu Huang M.D., David K. Roberts, III, M.D. FACC, Zijian Xu M.D., Ph.D., FACC
Status: Active, Recruiting
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Large-scale, pragmatic, cluster-randomized clinical trial to evaluate Direct vs. Digital
Engagement QI compared with usual care HF outcomes & care metrics.
Investigators: John Chin M.D., Zijian Xu M.D., Ph.D., FACC
Status: Active, Recruiting
CONNECT HF (SIMR)
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart
Failure (CONNECT-HF)
Investigators: John Chin M.D., Zijian Xu M.D., Ph.D., FACC
Status: Active, Recruiting
Entresto TM (LCZ696) In Advanced Heart Failure
Treatment with LCZ696 of patients with symptomatic, advanced heart failure due to
left ventricular systolic dysfunction for 24 weeks, compared to valsartan.
Investigator: Zijian Xu M.D., Ph.D., FACC
Status: Active, Recruiting
LIFE Study
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study) (HFN-LIFE)
Investigators: John Chin M.D., Zijian Xu M.D., Ph.D., FACC
Status: Active, Recruiting
VICTORIA Heart Failure
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction
(HFrEF) (MK-1242-001) (VICTORIA)
Investigator: Zijian Xu M.D., Ph.D., FACC
Status: Active, Recruiting